ncRNA name
hsa-miR-200b
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
BCL2/XIAP
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Cisplatin/Vincristine
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Overexpression of miR-200bc/429 cluster sensitized SGC7901/VCR and A549/CDDP cells to anti-cancer drugs, respectively.
Tissue resource
human gastric adenocarcinoma cell lines SGC7901
human gastric adenocarcinoma multidrug-resistant cell lines SGC7901/VCR
human lung cancer cell lines A549
human lung cancer multidrug-resistant cell lines A549/CDDP
human gastric adenocarcinoma cell lines SGC7901
human gastric adenocarcinoma multidrug-resistant cell lines SGC7901/VCR
human lung cancer cell lines A549
human lung cancer multidrug-resistant cell lines A549/CDDP
human gastric adenocarcinoma cell lines SGC7901
human gastric adenocarcinoma multidrug-resistant cell lines SGC7901/VCR
human lung cancer cell lines A549
human lung cancer multidrug-resistant cell lines A549/CDDP
Experiment
qRT-PCR,Western blot,Dual-luciferase reporter assay
Institute
Academy of Military Medical Science
the Xijing Hospital of Fourth Military Medical University
Biosis Biotechnology Company
Academy of Military Medical Science
Xijing Hospital, Fourth Military Medical University
Biosis Biotechnology Company
Academy of Military Medical Science
Xijing Hospital, Fourth Military Medical University
Biosis Biotechnology Company
Country
China
China
China
Continent
Asia
Asia
Asia